Literature DB >> 1398955

Effect of gamma interferon on resolution of murine chlamydial genital infection.

R G Rank1, K H Ramsey, E A Pack, D M Williams.   

Abstract

Mice infected in the genital tract with the Chlamydia trachomatis agent of mouse pneumonitis were treated with monoclonal rat anti-gamma interferon (anti-IFN-gamma) antibody to determine whether IFN-gamma participated in the resolution of the infection. In two experiments, anti-IFN-gamma antibody treatment resulted in significantly prolonged infections. In support of these data, passive administration of recombinant IFN-gamma to chronically infected nu/nu mice was able to bring about resolution of the infection in some animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398955      PMCID: PMC257484          DOI: 10.1128/iai.60.10.4427-4429.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis.

Authors:  R G Rank; L S Soderberg; M M Sanders; B E Batteiger
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis.

Authors:  R G Rank; H J White; A L Barron
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs.

Authors:  R G Rank; A L Barron
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice.

Authors:  D M Williams; G I Byrne; B Grubbs; T J Marshal; J Schachter
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

6.  Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs.

Authors:  R G Rank; A L Barron
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Chronic chlamydial genital infection in congenitally athymic nude mice.

Authors:  R G Rank; L S Soderberg; A L Barron
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

8.  Long-term effects of gamma interferon on chlamydia-infected host cells: microbicidal activity follows microbistasis.

Authors:  G I Byrne; J M Carlin; T P Merkert; D L Arter
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.

Authors:  K H Ramsey; L S Soderberg; R G Rank
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo.

Authors:  G M Zhong; E M Peterson; C W Czarniecki; L M de la Maza
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more
  55 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon.

Authors:  R P Morrison
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers.

Authors:  S Kotake; H R Schumacher; T K Arayssi; H C Gérard; P J Branigan; A P Hudson; C H Yarboro; J H Klippel; R L Wilder
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection.

Authors:  Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

5.  Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome.

Authors:  K H Ramsey; G S Miranpuri; I M Sigar; S Ouellette; G I Byrne
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

Authors:  J M Vuola; V Puurula; M Anttila; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

7.  Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.

Authors:  Gail L Sturdevant; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2014-04-10       Impact factor: 3.166

8.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

Authors:  J U Igietseme; P B Wyrick; D Goyeau; R G Rank
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model.

Authors:  Uma M Nagarajan; Daniel Prantner; James D Sikes; Charles W Andrews; Anna M Goodwin; Shanmugam Nagarajan; Toni Darville
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.